UNH vs MRK
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Merck & Company, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | MRK |
|---|---|---|
| Price | $405.59 | $132.92 |
| Market cap | $364.06B | $327.94B |
| P/E ratio | 26.0 | 106.3 |
| ROE | 14.15% | 6.96% |
| Profit margin | 3.14% | 4.77% |
| Revenue growth | 0.40% | 5.10% |
| Dividend yield | 2.29% | 2.56% |
| Beta | 0.63 | 0.21 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs MRK in plain English
- UNH and MRK are similar in size.
- UNH is cheaper on earnings (P/E 26.0 vs 106.3).
- UNH earns a higher return on equity (14% vs 7%).
- MRK is growing revenue faster (5% vs 0%).
- MRK has the higher dividend yield (2.56% vs 2.29%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.